Jack Farr, MD, of Indianapolis-based OrthoIndy, performed the state's first meniscus replacement with Active Implants' NUsurface Meniscus Implant.
Here are four key points:
1. OrthoIndy is participating in the VENUS clinical trial, which involves patients with knee pain following meniscus cartilage loss.
2. The trial is testing the safety and efficacy of the investigational NUsurface compared to non-surgical standard of care.
3. Surgeons insert the implant into the knee joint via a small incision. Following surgery, patients have a six-week rehabilitation period.
4. Surgeons have used the NUsurface in Europe since 2008 and in Israel since 2011.